Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Ovarian Epithelial × Everolimus × Clear all

Sponsor

Conditions

Breast Neoplasms 34 Carcinoma, Renal Cell 29 Neoplasms 17 Kidney Neoplasms 15 Neuroendocrine Tumors 13 Neoplasm Metastasis 12 Tuberous Sclerosis 8 Prostatic Neoplasms 8 Carcinoma 8 Lymphoma, Mantle-Cell 7 Hodgkin Disease 7 Waldenstrom Macroglobulinemia 6 Recurrence 6 Lymphoma, Large B-Cell, Diffuse 6 Head and Neck Neoplasms 6 Glioma 6 Triple Negative Breast Neoplasms 5 Ovarian Neoplasms 5 Lymphoma 5 Glioblastoma 5 Colorectal Neoplasms 5 Carcinoma, Neuroendocrine 5 Brain Neoplasms 5 Astrocytoma 5 Sezary Syndrome 4 Sarcoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Pancreatic Neoplasms 4 Mycosis Fungoides 4 Melanoma 4

Interventions

Paclitaxel 21 Carboplatin 16 liposomal doxorubicin 12 Bevacizumab 8 Topotecan 7 Docetaxel 7 Cisplatin 7 pembrolizumab 6 rucaparib 5 mirvetuximab soravtansine 5 Gemcitabine 5 Cyclophosphamide 5 Taxes 4 Albumin-Bound Paclitaxel 4 sargramostim 3 ixabepilone 3 Cytoreduction Surgical Procedures 3 130-nm albumin-bound paclitaxel 3 taxane 2 talazoparib 2 pazopanib 2 fludarabine phosphate 2 fludarabine 2 denileukin diftitox 2 cediranib 2 catumaxomab 2 belinostat 2 avelumab 2 aflibercept 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡